Patents: the public interest versus the private privilege.

Suppr

超能文献

作者信息

Parsi Kayhan P, Egan Erin A

机构信息

Loyola University Chicago.

出版信息

Am J Bioeth. 2002 Summer;2(3):45-6. doi: 10.1162/152651602760250138.

DOI:10.1162/152651602760250138

PMID:12230857

Abstract

摘要

相似文献

Patents: the public interest versus the private privilege.

Am J Bioeth. 2002 Summer;2(3):45-6. doi: 10.1162/152651602760250138.

Life, death, and monopoly rights in a democratic society.

Am J Bioeth. 2002 Summer;2(3):43-4. doi: 10.1162/152651602760250129.

Not taking, just borrowing: government use of patented drugs.

Am J Bioeth. 2002 Summer;2(3):51-2. doi: 10.1162/152651602760250174.

Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.

Am J Bioeth. 2002 Summer;2(3):29-39. doi: 10.1162/152651602760250084.

It is not unethical, though it is often unwise, to override patents.

Am J Bioeth. 2002 Summer;2(3):50-1. doi: 10.1162/152651602760250165.

Compulsory licensure: the case of Cipro and beyond.

Am J Bioeth. 2002 Summer;2(3):40. doi: 10.1162/152651602760250093.

Who are the guardians guarding?

Am J Bioeth. 2002 Summer;2(3):46-8. doi: 10.1162/152651602760250147.

The Cipro patent and bioterrorism.

Am J Bioeth. 2002 Summer;2(3):41-2. doi: 10.1162/152651602760250101.

Patent immorality?

Am J Bioeth. 2002 Summer;2(3):48-9. doi: 10.1162/152651602760250156.

Beyond government intervention: drug companies and bioethics.

Am J Bioeth. 2002 Summer;2(3):42-3. doi: 10.1162/152651602760250110.

引用本文的文献

Three Proposals for Rewarding Novel Health Technologies Benefiting People Living in Poverty. A Comparative Analysis of Prize Funds, Health Impact Funds and a Cost-Effectiveness/Competitive Tender Treaty.

Public Health Ethics. 2008 Jul;1(2):146-153. doi: 10.1093/phe/phn013. Epub 2008 May 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Patents: the public interest versus the private privilege.

Am J Bioeth. 2002 Summer;2(3):45-6. doi: 10.1162/152651602760250138.

Life, death, and monopoly rights in a democratic society.

Am J Bioeth. 2002 Summer;2(3):43-4. doi: 10.1162/152651602760250129.

Not taking, just borrowing: government use of patented drugs.

Am J Bioeth. 2002 Summer;2(3):51-2. doi: 10.1162/152651602760250174.

Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.

Am J Bioeth. 2002 Summer;2(3):29-39. doi: 10.1162/152651602760250084.

It is not unethical, though it is often unwise, to override patents.

Am J Bioeth. 2002 Summer;2(3):50-1. doi: 10.1162/152651602760250165.

Compulsory licensure: the case of Cipro and beyond.

Am J Bioeth. 2002 Summer;2(3):40. doi: 10.1162/152651602760250093.

Who are the guardians guarding?

Am J Bioeth. 2002 Summer;2(3):46-8. doi: 10.1162/152651602760250147.

The Cipro patent and bioterrorism.

Am J Bioeth. 2002 Summer;2(3):41-2. doi: 10.1162/152651602760250101.

Patent immorality?

Am J Bioeth. 2002 Summer;2(3):48-9. doi: 10.1162/152651602760250156.

Beyond government intervention: drug companies and bioethics.

Am J Bioeth. 2002 Summer;2(3):42-3. doi: 10.1162/152651602760250110.

引用本文的文献

Public Health Ethics. 2008 Jul;1(2):146-153. doi: 10.1093/phe/phn013. Epub 2008 May 3.